Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference
September 29 2022 - 10:04AM
Biofrontera
Inc. (Nasdaq: BFRI),
a biopharmaceutical company specializing in the commercialization
of dermatological products, announced today that Erica Monaco,
Chief Executive Officer, will present at the Roth Inaugural
Healthcare Opportunities Conference being held at the Yale Club in
New York City on October 6, 2022. Management will also be
participating in one-on-one investor meetings at the conference.
Event: |
Roth Inaugural Healthcare Opportunities Conference |
Date: |
Thursday, October 6, 2022 |
Time: |
8:30 a.m. Eastern Time |
Investors registered for the conference are
encouraged to contact their Roth representative to schedule a
one-on-one meeting with management during the conference.
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based
biopharmaceutical company commercializing a portfolio of
pharmaceutical products for the treatment of dermatological
conditions with a focus on photodynamic therapy (PDT) and topical
antibiotics. The Company’s licensed products are used for the
treatment of actinic keratoses, which are pre-cancerous skin
lesions, as well as impetigo, a bacterial skin infection. For more
information, visit www.biofrontera-us.com.
Contacts:
Biofrontera Inc.Anke zur
Mühlen+1 781 486 1539us-ir@biofrontera.com
LHA Investor RelationsTirth T.
Patel+1 212 201 6614tpatel@lhai.com
# # #
Biofrontera (NASDAQ:BFRIW)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biofrontera (NASDAQ:BFRIW)
Historical Stock Chart
From Jul 2023 to Jul 2024